Chemoimmunotherapy for cutaneous melanoma with dacarbazine and epifocal contact sensitizers: results of a nationwide survey of the German Dermatologic Co-operative Oncology Group
Purpose: To scrutinize published data from small mono-centric studies and case reports which implicated high response rates and promising survival times for a combination therapy consisting of epifocal dinitrochlorobenzene (DNCB) and dacarbazine (DTIC) for metastasized melanoma. This therapy merges...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
03 March 2007
|
| In: |
Journal of cancer research and clinical oncology
Year: 2007, Jahrgang: 133, Heft: 7, Pages: 437-444 |
| ISSN: | 1432-1335 |
| DOI: | 10.1007/s00432-006-0182-9 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00432-006-0182-9
|
| Verfasserangaben: | P. Terheyden, A.-K. Kortüm, H.-J. Schulze, B. Durani, R. Remling, C. Mauch, V. Junghans, D. Schadendorf, U. Beiteke, M. Jünger, J.C. Becker, E.-B. Bröcker |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 174748685X | ||
| 003 | DE-627 | ||
| 005 | 20230426111201.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210205s2007 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00432-006-0182-9 |2 doi | |
| 035 | |a (DE-627)174748685X | ||
| 035 | |a (DE-599)KXP174748685X | ||
| 035 | |a (OCoLC)1341391768 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Terheyden, Patrick |d 1970- |e VerfasserIn |0 (DE-588)120128772 |0 (DE-627)080465366 |0 (DE-576)292055285 |4 aut | |
| 245 | 1 | 0 | |a Chemoimmunotherapy for cutaneous melanoma with dacarbazine and epifocal contact sensitizers |b results of a nationwide survey of the German Dermatologic Co-operative Oncology Group |c P. Terheyden, A.-K. Kortüm, H.-J. Schulze, B. Durani, R. Remling, C. Mauch, V. Junghans, D. Schadendorf, U. Beiteke, M. Jünger, J.C. Becker, E.-B. Bröcker |
| 264 | 1 | |c 03 March 2007 | |
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 05.02.2021 | ||
| 520 | |a Purpose: To scrutinize published data from small mono-centric studies and case reports which implicated high response rates and promising survival times for a combination therapy consisting of epifocal dinitrochlorobenzene (DNCB) and dacarbazine (DTIC) for metastasized melanoma. This therapy merges the effects of an allergic contact dermatitis elicited at the site of a cutaneous metastasis, and systemic chemotherapy. Methods: We performed a retrospective survey with nine German centers and evaluated 72 patients treated from 1993 to 2005. Results: The objective response rate in stage III melanoma (n = 39) was 62%. In contrast, only 9% objective responses were observed in 33 stage IV patients. Interestingly, more than half of patients with objective remissions remained progression-free for more than 1 year irrespective of the stage of disease. Conclusions: Epifocal DNCB combined with DTIC is effective in patients with regionally metastasized melanoma not amenable to surgery or isolated limb perfusion, whereas in stage IV disease in spite of few durable remissions the addition of DNCB does not improve the therapeutic efficacy of DTIC. | ||
| 700 | 1 | |a Schadendorf, Dirk |d 1960- |e VerfasserIn |0 (DE-588)11142576X |0 (DE-627)499566076 |0 (DE-576)289702275 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of cancer research and clinical oncology |d Berlin : Springer, 1979 |g 133(2007), 7, Seite 437-444 |h Online-Ressource |w (DE-627)253769515 |w (DE-600)1459285-X |w (DE-576)072578319 |x 1432-1335 |7 nnas |a Chemoimmunotherapy for cutaneous melanoma with dacarbazine and epifocal contact sensitizers results of a nationwide survey of the German Dermatologic Co-operative Oncology Group |
| 773 | 1 | 8 | |g volume:133 |g year:2007 |g number:7 |g pages:437-444 |g extent:8 |a Chemoimmunotherapy for cutaneous melanoma with dacarbazine and epifocal contact sensitizers results of a nationwide survey of the German Dermatologic Co-operative Oncology Group |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s00432-006-0182-9 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210205 | ||
| 993 | |a Article | ||
| 994 | |a 2007 | ||
| 998 | |g 11142576X |a Schadendorf, Dirk |m 11142576X:Schadendorf, Dirk |d 50000 |e 50000PS11142576X |k 0/50000/ |p 8 | ||
| 999 | |a KXP-PPN174748685X |e 3849177831 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Gesehen am 05.02.2021"],"recId":"174748685X","id":{"eki":["174748685X"],"doi":["10.1007/s00432-006-0182-9"]},"title":[{"title":"Chemoimmunotherapy for cutaneous melanoma with dacarbazine and epifocal contact sensitizers","title_sort":"Chemoimmunotherapy for cutaneous melanoma with dacarbazine and epifocal contact sensitizers","subtitle":"results of a nationwide survey of the German Dermatologic Co-operative Oncology Group"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedDisp":"03 March 2007","dateIssuedKey":"2007"}],"language":["eng"],"relHost":[{"titleAlt":[{"title":"Cancer research and clinical oncology"}],"pubHistory":["Volume 93, issue 1 (January 1979)-"],"recId":"253769515","title":[{"subtitle":"official organ of the Deutsche Krebsgesellschaft","title_sort":"Journal of cancer research and clinical oncology","title":"Journal of cancer research and clinical oncology"}],"id":{"eki":["253769515"],"zdb":["1459285-X"],"issn":["1432-1335"]},"note":["Gesehen am 19.03.25","Teils ungezählte Beil.: Supplement"],"disp":"Chemoimmunotherapy for cutaneous melanoma with dacarbazine and epifocal contact sensitizers results of a nationwide survey of the German Dermatologic Co-operative Oncology GroupJournal of cancer research and clinical oncology","physDesc":[{"extent":"Online-Ressource"}],"part":{"text":"133(2007), 7, Seite 437-444","issue":"7","volume":"133","extent":"8","year":"2007","pages":"437-444"},"origin":[{"dateIssuedKey":"1979","publisherPlace":"Berlin ; Heidelberg","dateIssuedDisp":"1979-","publisher":"Springer"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng","ger"]}],"name":{"displayForm":["P. Terheyden, A.-K. Kortüm, H.-J. Schulze, B. Durani, R. Remling, C. Mauch, V. Junghans, D. Schadendorf, U. Beiteke, M. Jünger, J.C. Becker, E.-B. Bröcker"]},"person":[{"display":"Terheyden, Patrick","role":"aut","given":"Patrick","roleDisplay":"VerfasserIn","family":"Terheyden"},{"role":"aut","display":"Schadendorf, Dirk","given":"Dirk","family":"Schadendorf","roleDisplay":"VerfasserIn"}],"physDesc":[{"extent":"8 S."}]} | ||
| SRT | |a TERHEYDENPCHEMOIMMUN0320 | ||